CIK 0001348362 · Non-accelerated filer<br>Smaller reporting company
Lexaria Bioscience Corp.
Sign in to watch- Ticker
- LEXX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Aug 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 202000871
- Phone
- 250-765-6424
- Business address
- 100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, V1X 2P7
- Former names
- Lexaria Corp., LEXARIA CORP.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-31 | Carle Vanessa Secretary | Sale | −2,567 | $4.00 | $10K | 0 |
| 2024-07-26 | REESE ALBERT L JR Director | Grant or award · Stock Options | +12,000 | 32,000 | ||
| 2024-07-26 | TURKEL CATHERINE C. Director | Grant or award · Stock Options | +12,000 | 27,000 | ||
| 2024-07-26 | Baxter Nicholas W Director | Grant or award · Stock Options | +12,000 | 52,000 | ||
| 2024-07-26 | McKechnie William Edward Director | Grant or award · Stock Options | +12,000 | 52,000 | ||
| 2024-05-14 | Carle Vanessa Secretary | Option exercise | +2,500 | $1.15 | $3K | 2,567 |
| 2024-05-14 | Carle Vanessa Secretary | Option exercise · Stock Options | −2,500 | 60,067 | ||
| 2024-04-26 | Carle Vanessa Secretary | Grant or award · Stock Options | +10,000 | 62,567 | ||
| 2024-04-26 | TURKEL CATHERINE C. Director | Grant or award · Stock Options | +5,000 | 15,000 | ||
| 2024-04-26 | Baxter Nicholas W Director | Grant or award · Stock Options | +5,000 | 40,000 | ||
| 2024-04-26 | McKechnie William Edward Director | Grant or award · Stock Options | +5,000 | 40,000 | ||
| 2024-04-26 | REESE ALBERT L JR Director | Grant or award · Stock Options | +5,000 | 20,000 | ||
| 2024-04-26 | BUNKA CHRISTOPHER Chief Executive Officer | Grant or award · Stock Options | +49,500 | 180,501 | ||
| 2024-04-26 | DOCHERTY JOHN MARTIN President | Grant or award · Stock Options | +49,500 | 174,168 | ||
| 2023-10-26 | Carle Vanessa Secretary | Grant or award · Stock Options | +12,500 | 52,567 | ||
| 2023-10-26 | DOCHERTY JOHN MARTIN President | Grant or award · Stock Options | +30,000 | 124,668 | ||
| 2023-10-26 | BUNKA CHRISTOPHER Chief Executive Officer | Grant or award · Stock Options | +30,000 | 131,001 | ||
| 2023-07-25 | Baxter Nicholas W Director | Grant or award · Stock Options | +5,000 | 35,000 | ||
| 2023-07-25 | McKechnie William Edward Director | Grant or award · Stock Options | +5,000 | 35,000 | ||
| 2023-07-25 | REESE ALBERT L JR Director | Grant or award · Stock Options | +5,000 | 15,000 |
Page 2 of 6 · 118 trades